Patents by Inventor Doreen LePage

Doreen LePage has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antitumoral treatments
    Patent number: 8258098
    Abstract: The present invention relates to combinations of aplidine or aplidine analogues with other titumoral agents, and the use of these combinations in the treatment of cancer, in particular in the treatment of lung cancer, breast cancer, colon cancer, prostate cancer, renal cancer, melanoma, multiple myeloma, leukemia and lymphoma.
    Type: Grant
    Filed: February 28, 2007
    Date of Patent: September 4, 2012
    Assignee: Pharma Mar, S.A.
    Inventors: Glynn Thomas Faircloth, Pablo Manuel Aviles Marin, Doreen LePage, Jesus San Miguel Izquierdo, Atanasio Pandiella
  • Combination Therapy with an Antitumor Alkaloid
    Publication number: 20110070232
    Abstract: The present invention relates to combinations of PM00104 with other anticancer drugs, and the use of these combinations in the treatment of cancer.
    Type: Application
    Filed: May 18, 2009
    Publication date: March 24, 2011
    Applicant: Pharma Mar, S.A.
    Inventors: Doreen LePage, Pablo Manuel Aviles Marin, Maria Jose Guillen Navarro
  • Anticancer Treatments
    Publication number: 20110009335
    Abstract: The present invention relates to combinations of aplidine with another anticancer drug selected from sorafenib, temsirolimus, and sunitinib, and the use of these combinations in the treatment of cancer.
    Type: Application
    Filed: March 6, 2009
    Publication date: January 13, 2011
    Inventors: Doreen LePage, Pablo Manuel Aviles Marin, Maria Jose Guillen
  • ANTITUMORAL TREATMENTS
    Publication number: 20090246168
    Abstract: The present invention relates to combinations of aplidine or aplidine analogues with other antitumoral agents, and the use of these combinations in the treatment of cancer, in particular in the treatment of lung cancer, breast cancer, colon cancer, prostate cancer, renal cancer, melanoma, multiple myeloma, leukemia and lymphoma.
    Type: Application
    Filed: February 28, 2007
    Publication date: October 1, 2009
    Applicant: PHARMA MAR, S.A.
    Inventors: Glynn Thomas Faircloth, Pablo Manuel Aviles Marin, Doreen LePage, Jesus San Miguel Izquierdo, Atanasio Pandiella
  • Lymphotoxin beta receptor agents in combination with chemotherapeutic agents
    Publication number: 20060134102
    Abstract: This invention features combination therapies that include a composition that activates lymphotoxin-beta receptor signaling in combination with one or more other chemotherapeutic agents, as well as therapeutic methods and screening methods for identifying agents that in combination with a lymphotoxin-beta receptor agonist agent have a supra-additive effect on tumor inhibition.
    Type: Application
    Filed: June 17, 2005
    Publication date: June 22, 2006
    Applicant: Biogen Idec MA Inc.
    Inventors: Doreen LePage, Alan Gill